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Introduction 
Amelogenin is the primary component of Emdogain®, which is used to regenerate periodontal defects 
prior to prosthodontic treatments.  Amelogenin is well known for its effect on nucleation/growth of 
hydroxyapatite crystals during enamel bio-mineralization.  In addition, recent studies suggest that 
amelogenin has a unique function to modulate osteogenic differentiation of mesenchymal stem cells (MSCs); 
however, molecular mechanisms by which amelogenin contributes to stem cells remain unknown. 
Amelogenin is also known to be involved in the organizing of enamel rods during tooth development. 
Tooth development is largely dependent on sequential and reciprocal epithelial-mesenchymal interactions.  
Bone morphogenetic protein-4 (Bmp4) is one of the key mesenchymal odontogenic signals for driving tooth 
morphogenesis.  Induced pluripotent stem cells (iPSCs) have potential to differentiate into dental epithelial 
and mesenchymal stem cells; therefore, controlled expression of amelogenin and Bmp4 in iPSCs may 
provide a new strategy to generate a bioengineered tooth. 
To investigate direct effects of amelogenin on stem cells, forced expression of amelogenin by the viral 
transduction is one of the most powerful and cost-effective methods.  Tet-controlled transcriptional 
activation is a method of inducible gene expression where transcription is reversibly turned on or off in the 
presence of a tetracycline (Tet) derivative (doxycycline: Dox).  In this study, I focused on the 
Tet-dependent lentiviral transcriptional regulatory system to control forced expression of exogenous 
amelogenin and Bmp4 genes in stem cells.   
The objectives of this study were first to establish a Tet-regulated system for amelogenin expression in 
MSCs and iPSCs, and second to investigate effects of exogenous expression of amelogenin on osteogenesis 
of MSCs, and third to explore a possibility to induce a bioengineered tooth by interaction of amelogenin 
expressing iPSCs and Bmp4 expressing iPSCs. 
Material and method 
1. Tet-controlled transcriptional activation of amelogenin during MSC osteogenesis 
I first investigated whether Tet-controlled transcriptional activation of amelogenin enhanced 
osteogenesis of MSCs.  Immortalized clonal mouse bone marrow-derived MSCs were lentivirally infected 
with the pLenti3.3/TetR expression vector, and transduced cells (MSCs-TetR) were selected by geneticin.  
A full-length mouse amelogenin-coding (Amelx) cDNA fragment was PCR-amplified and cloned into 
pENTRTM/D-TOPO vector using pENTR Directional TOPO cloning kit (Invitrogen).  Based on this entry 
vector, pLenti6.3/Tet operator (TO)/V5/-Amelx expression vector that contained the Amelx cDNA fragment 
was constructed using the Gateway® system and lentivirally introduced into MSCs-TetR to generate 
MSCs-TetR/Amelx. 
Tet-dependent expression of Amelx gene and protein in MSCs-TetR/Amelx was evaluated by RT-PCR 
and Western blotting in the presence or absence of Dox for 7-35 days.  Tet-dependent osteogenic marker 
gene [Osterix, Osteocalcin, Osteopontin, Bone sialoprotein (BSP), Type I collagen] expression, alkaline 
phosphatase (ALP) activity, mineralized nodule formation and calcium deposits were evaluated by RT-PCR 
(semi-quantitative RT-PCR and quantitative real-time RT-PCR analyses), ALP staining, von Kossa (VK) 
staining and quantitative alizarin red measurement assay, respectively. 
2. Tet-controlled transcriptional activation of amelogenin and Bmp4 in iPSCs 
I next investigated whether Tet-controlled transcriptional activation of amelogenin and Bmp4 induced 
odontogenesis of iPSCs.  Mouse gingiva-derived iPSCs were lentivirally infected with the pLenti3.3/TetR 
expression vector, and transduced cells (iPSCs-TetR) were selected by geneticin.  Expression of TetR gene 
in iPSCs-tetR was evaluated by RT-PCR and western blotting.  A full-length human Bmp4 cDNA was 
cloned into pLenti6.3/TO/V5 expression vector (pLenti6.3/TO/V5-Bmp4) using the Gateway® system.  
After that, iPSCs-tetR were transduced by pLenti6.3/TO/V5-Amelx and pLenti6.3/TO/V5-Bmp4 to generate 
iPSCs-tetR/Amelx and iPSCs-tetR/Bmp4, respectively.  Tet-dependent expression of Amelx and Bmp4 
gene and protein in iPSCs-tetR/Amelx and iPSCs-tetR/Bmp4 were evaluated by RT-PCR and Western 
blotting in the presence or absence of Dox. 
To investigate whether forced expression of amelogenin in iPSCs showed lineage-specific 
differentiation, embryonic bodies (EBs) of iPSCs-tetR/Amelx were cultured in the presence or absence of 
Dox, and were implanted under the skin of the mouse.  After 10 weeks, implanted tissues were extracted 
and histologically examined by hematoxylin and eosin (HE) staining.  EBs of iPSCs-tetR/Amelx and 
iPSCs-tetR/Bmp4 were co-cultured in the presence or absence of Dox for 21 days, and expression of 
ameloblast-lineage marker gene (amelogenin) and odontoblast-lineage marker gene (dentin matrix acidic 
phosphoprotein 1: DMP1) was examined by RT-PCR.   
Results 
1. Tet-controlled transcriptional activation of amelogenin enhanced MSC osteogenesis 
When MSCs-TetR/Amelx were cultured in the presence of Dox, enhanced gene expression of Amelx 
was confirmed after 24 hours.  Western blotting analysis showed that Dox stimulated MSCs-TetR/Amelx to 
express Amelx protein after 48 hours.  In contrast, no background expression of Amelx protein was 
observed when MSCs-TetR/Amelx were cultured in the absence of Dox.  Corresponding to the increased 
expression of Amelx with the addition of Dox, osteogenesis marker genes (osterix, BSP, osteocalcin and type 
I collagen) expressed significantly higher than the cells cultured without Dox (ANOVA; P<0.01).  Forced 
expression of Amelx increased ALP activity after 14 days and the mineralized nodule formation after 21 
days during osteogenic differentiation.  Quantitative analysis of calcification demonstrated that forced 
expression of Amelx significantly induced calcium deposition of MSCs-TetR/Amelx after 14 days until 21 
days in osteogenic induction medium (ANOVA; P<0.01). 
2. Tet-controlled transcriptional activation of amelogenin and Bmp4 induced odontogenic differentiation 
of iPSCs 
Enhanced gene and protein expression of Amelx and Bmp4 was detected after 48 hours in the presence 
of Dox in iPSCs-tetR/Amelx and iPSCs-tetR/Bmp4, respectively.  Histological observation of the 
transplanted iPSCs-tetR/Amelx indicated that the cells predominantly formed keratinocyte-like cells and 
epidermis-like tissues in the presence of Dox, while the cells cultured in the absence of Dox formed teratoma 
that characteristically had cells and tissues from all three germ layers. Co-culture of EBs of 
iPSCs-tetR/Amelx and iPSCs-tetR/Bmp4 in the presence of Dox showed significantly higher expression of 
amelogenin and DMP1 compared to those in the absence of Dox (ANOVA; P<0.01). 
Conclusions
These results suggest that Tet-controlled Amelx gene regulation systems for MSCs and iPSCs were 
successfully established.  Transcriptional activation of Amelx enhances osteogenic differentiation of MSCs 
by up-regulating osterix, BSP, osteocalcin and type I collagen genes.  Interaction of amelogenin expressing 
iPSCs and Bmp4 expressing iPSCs may lead odontogenic differentiation.  These findings represent 
important steps toward the optimal application of amelogenin therapy for periodontal/bone regeneration and 
the new strategy for a bioengineered tooth. 
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